PARDES BIOSCIENCES, INC.

CA

Developing oral anti-virals for COVID-19 and other Pan-coronaviruses.

Filings
7
Firms Hired
1
Total Expenses
$720,000
Years Active
2022–2023

Filings

YearFirmPeriodExpensesDoc
2022 PARDES BIOSCIENCES, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$120,000
2022 PARDES BIOSCIENCES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$120,000
2022 PARDES BIOSCIENCES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$120,000
2022 PARDES BIOSCIENCES, INC. 1st Quarter (Jan 1 - Mar 31)
AMENDED
$120,000
2022 PARDES BIOSCIENCES, INC. 1st Quarter (Jan 1 - Mar 31)
Registration
Firms Hired
FirmFilingsExpenses
PARDES BIOSCIENCES, INC. 7 $720,000
Issue Areas